Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2025 ,inter alia, to consider and approve Subdivision/ Stock Split of Equity Shares of the Company, subject to approval of the shareholders the Company and other necessary approvals